Found 98 matching trials
A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy Subjects PHASE1 Compare the effect of exenatide (therapeutic and supratherapeutic concentra...
Show More Learn More & Join Trial
Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes PHASE3 The study examines the Safety and efficacy study of exenatide once weekly i...
Show More Learn More & Join Trial
A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes PHASE1 The purpose of this study is to investigate the safety and effectiveness of...
Show More Location
Orange County Research Center
Learn More & Join Trial
Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes PHASE1 This study investigated a 4-week adjunctive therapy of either a GLP-1 analo...
Show More Location
Profil Institut für Stoffwechselforschung GmbH
Learn More & Join Trial
GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes PHASE4 This is a prospective study to evaluate effect of Exenatide extended releas...
Show More Location
Diabetes Endocrinology Research Center of WNY
Learn More & Join Trial
GLP-1 REceptor Agonists and Real World EvIdeNce N/A Glucagon-like peptide-1 receptor agonists (GLP-1RA) are powerful second-lin...
Show More Location
Servizio di Diabetologia UOC Medicina Generale
Learn More & Join Trial
A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes PHASE3 Phase 3 study to compare treatment with ITCA 650 to sitagliptin when added ...
Show More Location
Intarcia Therapeutics, Inc
Learn More & Join Trial
The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients PHASE3 This is a 28-week, multi-center, randomized, double-blind, placebo-controll...
Show More Location
Diabeteszentrum Oldenburg
Learn More & Join Trial
Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabetes PHASE4 Mortality due to cardiovascular problems is increased by having Diabetes Me...
Show More Location
Instituto de terapeutica Experimental y Clinica. Centro universitario de Ciencias de la Salud. Universidad de Guadalajara
Learn More & Join Trial
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus PHASE3 Study D5553C00002 is a multicenter, randomized, double-blind, placebo-contr...
Show More Learn More & Join Trial